Medifast, Inc. (MED)
Pre-market:
| Previous close | 32.25 |
| Open | 32.78 |
| Bid | 0.00 x 800 |
| Ask | 0.00 x 1200 |
| Day's range | 31.74 - 33.52 |
| 52-week range | 30.95 - 109.52 |
| Volume | |
| Avg. volume | 387,133 |
| Market cap | 347.352M |
| Beta (5Y monthly) | 1.15 |
| PE ratio (TTM) | 3.50 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 6.60 (20.70%) |
| Ex-dividend date | 18 Sept 2023 |
| 1y target est | N/A |
- Business Wire
Medifast to Announce Financial Results for the First Quarter Ended March 31, 2024
BALTIMORE, April 15, 2024--Medifast (NYSE: MED), the health and wellness company known for its habit-based and Coach-guided lifestyle solution, OPTAVIA®, will announce financial results for the first quarter ended March 31, 2024 on Monday, April 29, 2024, after market close. The Company will host a conference call to discuss the results with additional comments and details. Company participants will be Dan Chard, Chairman and Chief Executive Officer, and Jim Maloney, Chief Financial Officer.
- Business Wire
Medifast Announces Fourth Quarter and Full Year 2023 Financial Results
BALTIMORE, February 20, 2024--Medifast (NYSE: MED), the health and wellness company known for its habit-based and Coach-guided lifestyle solution, OPTAVIA®, today reported results for the fourth quarter and full year ended December 31, 2023.
- Business Wire
Medifast to Announce Financial Results for the Fourth Quarter and Full Year Ended December 31, 2023
BALTIMORE, February 06, 2024--Medifast (NYSE: MED), the health and wellness company known for its habit-based and Coach-guided lifestyle solution, OPTAVIA®, will announce financial results for the fourth quarter and full year ended December 31, 2023 on Tuesday, February 20, 2024, after market close. The Company will host a conference call to discuss the results with additional comments and details. Company participants will be Dan Chard, Chairman and Chief Executive Officer, and Jim Maloney, Chi
